Jennifer is a Managing Director in the Healthcare Equity Capital Markets team at Citigroup based in New York. She has over 15 years of capital markets and banking experience advising both private and public healthcare companies on their capital raising needs. She has advised on more than $12 billion of capital raised for her clients over the course of her career.
Prior to joining Citigroup, Jennifer was the Head of Healthcare Equity Capital Markets at Deutsche Bank. She joined Deutsche Bank from Bank of America Merrill Lynch where she was a Director in Healthcare Equity Capital Markets. She started her career at UBS Investment Bank having worked in their New York, Los Angeles and Hong Kong offices.
Jennifer earned a B.A. in Finance and Accounting from the Leonard N. Stern School of Business.
Prior to joining Citigroup, Jennifer was the Head of Healthcare Equity Capital Markets at Deutsche Bank. She joined Deutsche Bank from Bank of America Merrill Lynch where she was a Director in Healthcare Equity Capital Markets. She started her career at UBS Investment Bank having worked in their New York, Los Angeles and Hong Kong offices.
Jennifer earned a B.A. in Finance and Accounting from the Leonard N. Stern School of Business.
Speaking In
4:00 PM - 4:45 PM (EST)
Monday, February 6
With biotechnology stock index values dipping 20% across the past year and IPO volume down more…
South Broadway Ballroom
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
